Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature
Enrica Torretta, Micaela Garziano, Mariacristina Poliseno, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10198-10198
Open Access | Times Cited: 57

Showing 26-50 of 57 citing articles:

Altered sphingolipid pathway in SARS-CoV-2 infected human lung tissue
Rabisa J. Khan, Sierra L. Single, Christopher S. Simmons, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Human motor neurons derived from induced pluripotent stem cells are susceptible to SARS-CoV-2 infection
Gioia Cappelletti, Claudia Colombrita, Fiona Limanaqi, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 7
Hydroxyzine Use and Mortality in Patients Hospitalized for COVID-19: A Multicenter Observational Study
Marina Sánchez‐Rico, Frédéric Limosin, Raphaël Vernet, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5891-5891
Open Access | Times Cited: 16
Association between benzodiazepine receptor agonist use and mortality in patients hospitalised for COVID-19: a multicentre observational study
Nicolas Hoertel, Marina Sánchez‐Rico, Erich Gulbins, et al.
Epidemiology and Psychiatric Sciences (2022) Vol. 31
Open Access | Times Cited: 11
COVID-19 and Alzheimer's Disease: Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved
Alicia B. Pomilio, Arturo A. Vitale, Alberto Lazarowski
Current Medicinal Chemistry (2022) Vol. 30, Iss. 35, pp. 3993-4031
Closed Access | Times Cited: 11
Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy
Vyoma Snehal Trivedi, Albert Frank Magnusen, Reena Rani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14340-14340
Open Access | Times Cited: 11
Differential abundance of lipids and metabolites related to SARS-CoV-2 infection and susceptibility
Oihane E. Albóniga, Elena Moreno, Javier Martínez‐Sanz, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Association of Altered Plasma Lipidome with Disease Severity in COVID-19 Patients
Zhengzheng Zhang, Naama Karu, Alida Kindt, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 296-296
Open Access | Times Cited: 2
Cerebrospinal fluid metabolomic and proteomic characterization of neurologic post-acute sequelae of SARS-CoV-2 infection
Shilan Chen, Jianhao Liang, Dingqiang Chen, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 209-222
Closed Access | Times Cited: 6
Lipid compartments and lipid metabolism as therapeutic targets against coronavirus
Daniella Cesar-Silva, Filipe S. Pereira‐Dutra, Ana L.M. Giannini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Skeletal Muscle and COVID-19: The Potential Involvement of Bioactive Sphingolipids
Elisabetta Meacci, Federica Pierucci, Mercedes Garcia‐Gil
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1068-1068
Open Access | Times Cited: 9
Acid sphingomyelinase (ASM) and COVID‐19: A review of the potential use of ASM inhibitors against SARS‐CoV‐2
Pedro José Tronco Pauletto, Cássia P. Delgado, João Batista Teixeira da Rocha
Cell Biochemistry and Function (2023) Vol. 41, Iss. 3, pp. 284-295
Closed Access | Times Cited: 5
Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19
Diana Mota Toro, Pedro V. da Silva‐Neto, Jonatan C. S. de Carvalho, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1938-1938
Open Access | Times Cited: 5
The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2
Simona Fenizia, Melania Gaggini, Cristina Vassalle
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 7956-7973
Open Access | Times Cited: 5
Nucleotide, Phospholipid, and Kynurenine Metabolites Are Robustly Associated with COVID-19 Severity and Time of Plasma Sample Collection in a Prospective Cohort Study
Haley Chatelaine, Yulu Chen, John Braisted, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 346-346
Open Access | Times Cited: 5
Antipsychotic use and 28-day mortality in patients hospitalized with COVID-19: A multicenter observational retrospective study
Marina Sánchez‐Rico, Alejandro Edán-Sánchez, Mark Olfson, et al.
European Neuropsychopharmacology (2023) Vol. 75, pp. 93-104
Open Access | Times Cited: 4
COVID-19 and cholesterol biosynthesis: Towards innovative decision support systems
Eva Kočar, Sonja Katz, Žiga Pušnik, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107799-107799
Open Access | Times Cited: 4
Dysregulated metabolites and lipids in serum of patients with acute hepatitis E: A longitudinal study
Shaheen Khan, Yashwant Kumar, Charu Sharma, et al.
Journal of Viral Hepatitis (2023) Vol. 30, Iss. 12, pp. 959-969
Open Access | Times Cited: 4
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping
Kexin Wang, Yutong Nie, Cole Maguire, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers
Jinchun Sun, Megan E. Peters, Li‐Rong Yu, et al.
Metabolomics (2024) Vol. 21, Iss. 1
Closed Access | Times Cited: 1
COVID-19 and its clinical severity are associated with alterations of plasma sphingolipids and enzyme activities of sphingomyelinase and ceramidase
Christiane Mühle, Andreas E. Kremer, Marcel Vetter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Effects of Omega-3 and Antioxidant Cocktail Supplement on Prolonged Bed Rest: Results from Serum Proteome and Sphingolipids Analysis
Pietro Barbacini, Dieter Blottner, Daniele Capitanio, et al.
Cells (2022) Vol. 11, Iss. 13, pp. 2120-2120
Open Access | Times Cited: 6
Deep Phenotyping of the Lipidomic Response in COVID and non-COVID Sepsis
Hu Meng, Arjun Sengupta, Emanuela Ricciotti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Novel Insight into the Serum Sphingolipid Fingerprint Characterizing Longevity
Pietro Barbacini, Enrica Torretta, Beatrice Arosio, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2428-2428
Open Access | Times Cited: 4
Starve a cold or feed a fever? Identifying cellular metabolic changes following infection and exposure to SARS-CoV-2.
Emma K. Loveday, Hope D. Welhaven, Ayten Ebru Erdogan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Scroll to top